These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11077846)

  • 1. [The monitoring of the drug resistance of the causative agent of tuberculosis in Russia in 1979-1998].
    Dorozhkova IR; Popov SA; Medvedeva IM
    Probl Tuberk; 2000; (5):19-22. PubMed ID: 11077846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The re-emergence of tuberculosis: the endemia of multiple-antibiotic-resistant strains].
    Rossi G
    Recenti Prog Med; 1996 Oct; 87(10):487-8. PubMed ID: 9026855
    [No Abstract]   [Full Text] [Related]  

  • 3. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis].
    Katalinić-Janković V; Obrovac M
    Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI
    Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of primary drug resistance of Mycobacterium tuberculosis from two hospitals in Tenerife, Canary Islands, Spain (1990-1997).
    Lecuona M; Alvarez R; Quintero J; Torres A; Hernández AM; Montesinos I; Sierra A
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):186-7. PubMed ID: 10694101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characterization of the drug resistance spectrum of rifampicin-resistant M. tuberculosis to other first-line antituberculous drugs].
    Isakova ZhT; Goncharova ZK; Aldashev AA
    Probl Tuberk Bolezn Legk; 2008; (11):39-42. PubMed ID: 19140379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analyzing the drug resistance of Mycobacterium tuberculosis in Russia's experimental areas introducing the WHO tuberculosis control programme].
    Sevast'ianova EV; Shul'gina MV; Puzanov VA; Martynova LP; Golyshevskaia VI; Erokhin VV
    Probl Tuberk; 2002; (12):11-4. PubMed ID: 12611326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 12. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current state of multidrug resistance in tuberculosis].
    Casal M; Gutiérrez J; Ruiz P
    Rev Esp Quimioter; 2000 Jun; 13(2):167-70. PubMed ID: 10918089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems of drug-resistant tuberculosis in the Republic of Tatarstan].
    Filatova MS; Valiev RSh
    Probl Tuberk Bolezn Legk; 2004; (12):22-5. PubMed ID: 15719661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia.
    Baranov AA; Mariandyshev AO; Mannsåker T; Dahle UR; Bjune GA
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1288-93. PubMed ID: 19793435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multidrug-resistant tuberculosis].
    Mori T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):192-4. PubMed ID: 10088371
    [No Abstract]   [Full Text] [Related]  

  • 19. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetics of Mycobacterium tuberculosis and genotyping of drug resistance.
    Ortona L; Cingolani A
    Rays; 1998; 23(1):42-7. PubMed ID: 9673133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.